A Study to Evaluate the Effect of ASP1941 in Adult Patients With Type 2 Diabetes Mellitus
A phase 2 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 412 participants.
Also called NCT01071850
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; quadruple masking; primary purpose treatment
- Phase
- Phase 2
- Enrolled
- 412 participants
- Sponsor
- Registry
-
NCT01071850
-
- Other papers using this trial's data
- Active- and placebo-controlled dose-finding study to assess the efficacy, safety, and tolerability of multiple doses of ipragliflozin in patients with type 2 diabetes mellitus
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- United States, Colombia, India, Mexico, Philippines
- Registry status
- Completed
Technical summary
Registry record NCT01071850. Randomized; quadruple masking; primary purpose treatment. Start 2010-03-03 (actual); primary completion 2011-04-11 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- A Study to Evaluate the Effect of ASP1941 in Adult Patients With Type 2 Diabetes Mellitus
- Condition
- Diabetes Mellitus, Type 2
- Intervention (Drug)
- ipragliflozin
- Intervention (Drug)
- Metformin
- Intervention (Drug)
- Placebo
- Lead sponsor
- Astellas Pharma Inc
Record details
- Record id
cardio:ct-nct01071850- Content hash
b8665df04c3cbd81a57a3629cb022bcdf54dbed47a3649ac4912d9077d8a90ae